174 related articles for article (PubMed ID: 17016514)
1. Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia.
Richter A; Sander SE; Rundfeldt C
Br J Pharmacol; 2006 Nov; 149(6):747-53. PubMed ID: 17016514
[TBL] [Abstract][Full Text] [Related]
2. Lower KV7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia.
Sander SE; Diwan M; Raymond R; Nobrega JN; Richter A
CNS Neurol Disord Drug Targets; 2016; 15(1):95-101. PubMed ID: 26553166
[TBL] [Abstract][Full Text] [Related]
3. KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
Li C; Huang P; Lu Q; Zhou M; Guo L; Xu X
Neuroscience; 2014 Nov; 280():19-30. PubMed ID: 25234320
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
[TBL] [Abstract][Full Text] [Related]
5. Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Kristensen LV; Sandager-Nielsen K; Hansen HH
Neurosci Lett; 2011 Jan; 488(2):178-82. PubMed ID: 21087654
[TBL] [Abstract][Full Text] [Related]
6. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel subtype selective M-current activators on spinal reflexes in vitro: Comparison with retigabine.
Vicente-Baz J; Lopez-Garcia JA; Rivera-Arconada I
Neuropharmacology; 2016 Oct; 109():131-138. PubMed ID: 27263036
[TBL] [Abstract][Full Text] [Related]
8. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
Zagorchev P; Apostolova E; Kokova V; Peychev L
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
Sotty F; Damgaard T; Montezinho LP; Mørk A; Olsen CK; Bundgaard C; Husum H
J Pharmacol Exp Ther; 2009 Mar; 328(3):951-62. PubMed ID: 19098162
[TBL] [Abstract][Full Text] [Related]
10. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
11. Sulfide Analogues of Flupirtine and Retigabine with Nanomolar K
Bock C; Surur AS; Beirow K; Kindermann MK; Schulig L; Bodtke A; Bednarski PJ; Link A
ChemMedChem; 2019 May; 14(9):952-964. PubMed ID: 30861620
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain.
Zhang F; Liu S; Jin L; Tang L; Zhao X; Yang T; Wang Y; Huo B; Liu R; Li H
Pharmacology; 2020; 105(7-8):471-476. PubMed ID: 32062659
[TBL] [Abstract][Full Text] [Related]
13. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
Richter A; Löschmann PA; Löscher W
Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
[TBL] [Abstract][Full Text] [Related]
14. Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
Sander SE; Lemm C; Lange N; Hamann M; Richter A
Neuropharmacology; 2012 Feb; 62(2):1052-61. PubMed ID: 22079161
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Jensen MM; Lange SC; Thomsen MS; Hansen HH; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):339-42. PubMed ID: 21599837
[TBL] [Abstract][Full Text] [Related]
16. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
17. KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus.
Ipavec V; Martire M; Barrese V; Taglialatela M; Currò D
Pharmacol Res; 2011 Oct; 64(4):397-409. PubMed ID: 21740972
[TBL] [Abstract][Full Text] [Related]
18. Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant.
Hamann M; Sander SE; Richter A
Eur J Pharmacol; 2008 May; 586(1-3):156-9. PubMed ID: 18353306
[TBL] [Abstract][Full Text] [Related]
19. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794
[TBL] [Abstract][Full Text] [Related]
20. Activation of peripheral KCNQ channels attenuates inflammatory pain.
Hayashi H; Iwata M; Tsuchimori N; Matsumoto T
Mol Pain; 2014 Feb; 10():15. PubMed ID: 24555569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
